Answers are grounded in this paper and cite their sources.
Pharmaceutical and device manufacturers regularly fund clinical trials to determine treatment efficacy. Are these sponsored trials designed to satisfy the marketing needs of the industry or to answer important clinical questions which will improve patient outcomes in healthcare? There exist incentives to industry funders to report clinically important results and conceal results which are not statistically significant. Industry sponsored studies are usually well planned and executed to minimize the conventional aspects of bias seen in randomized controlled trials (randomization, concealment allocation, blinding, intention to treat analysis). It is important to consider the possibility of different causes of bias when interpreting the results of industry sponsored studies.
No takes yet. Share an insight, caveat, or question.
Michael Turlik (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: